Read the full stored bill text
A3242 1R
[First Reprint]
ASSEMBLY, No. 3242
STATE OF NEW JERSEY
222nd LEGISLATURE
�
PRE-FILED FOR INTRODUCTION IN THE 2026 SESSION
Sponsored by:
Assemblyman DAN HUTCHISON
District 4 (Atlantic, Camden and Gloucester)
Assemblywoman MARGIE DONLON, M.D.
District 11 (Monmouth)
Assemblywoman� HEATHER SIMMONS
District 3 (Cumberland, Gloucester and Salem)
Co-Sponsored by:
Assemblyman Miller
SYNOPSIS
���� Requires health benefits coverage of continuous
glucose monitoring system for treatment of glycogen storage disease.
CURRENT VERSION OF TEXT
���� As reported by the Assembly Financial Institutions
and Insurance Committee on February 12, 2026, with amendments.
��
An Act
concerning health benefits coverage and continuous
glucose monitoring systems and supplementing various parts of the statutory
law.
����
Be It
Enacted
by the Senate and General Assembly of
the State of New Jersey:
���� 1.��� a.� A hospital service
corporation contract that provides hospital and medical expense benefits and is
delivered, issued, executed or renewed in this State pursuant to P.L.1938,
c.366 (C.17:48-1 et seq.), or approved for issuance or renewal in this State by
the Commissioner of Banking and Insurance, on or after the effective date of
this act, shall provide coverage for expenses incurred in the purchase and use
of a continuous glucose monitoring system, as prescribed by health care
practitioner for the treatment of glycogen storage disease.
���� b.��� The benefits shall be
provided to the same extent as for any other medical condition under the
contract.
���� c.���� This section shall
apply to those hospital service corporation contracts in which the hospital
service corporation has reserved the right to change the premium.
���� 2.��� a.� A medical service
corporation contract that provides hospital and medical expense benefits and is
delivered, issued, executed or renewed in this State pursuant to P.L.1940, c.74
(C.17:48A-1 et seq.), or approved for issuance or renewal in this State by the
Commissioner of Banking and Insurance, on or after the effective date of this
act, shall provide coverage for expenses incurred in the purchase and use of a continuous
glucose monitoring system, as prescribed by health care practitioner for the
treatment of glycogen storage disease.
���� b.��� The benefits shall be
provided to the same extent as for any other medical condition under the
contract.
���� c.���� This section shall
apply to those medical service corporation contracts in which the medical
service corporation has reserved the right to change the premium.
���� 3.��� a.� A health service
corporation contract that provides hospital and medical expense benefits and is
delivered, issued, executed or renewed in this State pursuant to P.L.1985,
c.236 (C.17:48E-1 et seq.), or approved for issuance or renewal in this State
by the Commissioner of Banking and Insurance, on or after the effective date of
this act, shall provide coverage for expenses incurred in the purchase and use
of a continuous glucose monitoring system, as prescribed by health care
practitioner for the treatment of glycogen storage disease.
���� b.��� The benefits shall be
provided to the same extent as for any other medical condition under the
contract.
���� c.���� This section shall
apply to those health service corporation contracts in which the health service
corporation has reserved the right to change the premium.
���� 4.��� a. �An individual health
insurance policy that provides hospital and medical expense benefits and is
delivered, issued, executed or renewed in this State pursuant to N.J.S.17B:26-1
et seq., or approved for issuance or renewal in this State by the Commissioner
of Banking and Insurance, on or after the effective date of this act, shall
provide coverage for expenses incurred in the purchase and use of a continuous
glucose monitoring system, as prescribed by health care practitioner for the
treatment of glycogen storage disease.
���� b.��� The benefits shall be
provided to the same extent as for any other medical condition under the
policy.
���� c.���� This section shall
apply to those individual health insurance policies in which the insurer has
reserved the right to change the premium.
���� 5.��� a.� A group health
insurance policy that provides hospital and medical expense benefits and is
delivered, issued, executed or renewed in this State pursuant to
N.J.S.17B:27-26 et seq., or approved for issuance or renewal in this State by
the Commissioner of Banking and Insurance, on or after the effective date of
this act, shall provide coverage for expenses incurred in the purchase and use
of a continuous glucose monitoring system, as prescribed by health care
practitioner for the treatment of glycogen storage disease.
���� b.��� The benefits shall be
provided to the same extent as for any other medical condition under the
policy.
���� c.���� This section shall
apply to those group health insurance policies in which the insurer has
reserved the right to change the premium.
���� 6.��� a.� An individual health
benefits plan that provides hospital and medical expense benefits and is
delivered, issued, executed or renewed in this State pursuant to P.L.1992,
c.161 (C.17B:27A-2 et seq.), or approved for issuance or renewal
in this State by the Commissioner of Banking and Insurance, on or after the
effective date of this act, shall provide coverage for expenses incurred in the
purchase and use of a continuous glucose monitoring system, as prescribed by
health care practitioner for the treatment of glycogen storage disease.
���� b.��� The benefits shall be
provided to the same extent as for any other medical condition under the plan.
���� c.���� This section shall
apply to those health benefits plans in which the carrier has reserved the
right to change the premium.
���� 7.��� a.� A small employer
health benefits plan that provides hospital and medical expense benefits and is
delivered, issued, executed or renewed in this State pursuant to P.L.1992,
c.162 (C.17B:27A-17 et seq.), or approved for issuance or renewal in this State
by the Commissioner of Banking and Insurance, on or after the effective date of
this act, shall provide coverage for expenses incurred in the purchase and use
of a continuous glucose monitoring system, as prescribed by health care
practitioner for the treatment of glycogen storage disease.
���� b.��� The benefits shall be
provided to the same extent as for any other medical condition under the plan.
���� c.���� This section shall
apply to those health benefits plans in which the carrier has reserved the
right to change the premium.
���� 8.��� a.� A health maintenance
organization contract for health care services that is delivered, issued,
executed, or renewed in this State pursuant to P.L.1973, c.337 (C.26:2J-1 et
seq.), or approved for issuance or renewal in this State by the Commissioner of
Banking and Insurance, on or after the effective date of this act, shall
provide coverage for expenses incurred in the purchase and use of a continuous
glucose monitoring system, as prescribed by health care practitioner for the
treatment of glycogen storage disease.
���� b.��� The benefits shall be
provided to the same extent as for any other medical condition under the
contract.
���� c.���� This section shall
apply to those contracts for health care services under which the health
maintenance organization has reserved the right to change the schedule of
charges for enrollee coverage.
���� 9.��� a.� The State Health
Benefits Commission shall ensure that every contract purchased by the
commission on or after the effective date of this act that provides hospital
and medical expense benefits shall provide coverage for expenses incurred in the
purchase and use of a continuous glucose monitoring system, as prescribed by
health care practitioner for the treatment of glycogen storage disease.
���� b.��� The benefits shall be
provided to the same extent as for any other medical condition under the
contract.
���� 10.��� a.� The School
Employees� Health Benefits Commission shall ensure that every contract
purchased by the commission on or after the effective date of this act that
provides hospital and medical expense benefits shall provide coverage for
expenses incurred in the purchase and use of a continuous glucose monitoring
system, as prescribed by health care practitioner for the treatment of glycogen
storage disease.
���� b.��� The benefits shall be
provided to the same extent as for any other medical condition under the
contract.
���� 11.� This act shall take
effect on the first day of the seventh month next following enactment and shall
apply to
1
[
all health
benefits plans
]
policies and contracts
1
that are delivered, issued, executed
1
[
or
]
,
1
renewed
1
[
in this State
]
1
,
or approved for issuance or renewal in this State by the Commissioner of
Banking and Insurance, on or after the effective date of this act
1
,
except that section 6 of this act shall take effect and apply to policies and
contracts that are delivered, issued, executed, or renewed pursuant to
P.L.1992, c.161 (C.17B:27A-2 et seq.) on January 1, 2027
1
.